Lorenzini Apparels: The financial results for the period ended September 30, 2026
Lorenzini Apparels (LAL) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹201 crore.
What happened
Lorenzini Apparels (LAL) filed a disclosure with the exchanges on 12 November 2026 at 06:46 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Lorenzini Apparels is a micro-cap company, with a market value of about ₹201 crore.
The stock last traded at ₹11.62, against a 52-week range of ₹5.56–₹13.45 (13.6% below the high).
Before this filing the shares had moved +38.2% over the month and +34.0% over three months. Average daily turnover over the last 20 sessions was about ₹0.2 crore.
Promoters held 56.17% at the end of Q1 FY27. Foreign institutions owned 0.41% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 9 | 1 | 0.06 |
| Q2 FY26 | 17 | 1.4 | 0.08 |
| Q3 FY26 | 21 | 1.1 | 0.06 |
| Q4 FY26 | 26 | 0.9 | 0.05 |
| Q1 FY27 | 17 | 2.2 | 0.13 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 5.7% on average the next trading day and was up 4.0% on average after five days (2 filings with price data).
Market-wide, 11,631 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 11 Aug 2026 | Outcome Of Board Meeting Including Approval Of The Financial Results… | +1.6% | −1.0% |
| 28 May 2026 | Financial Results For The Quarter And Financial Year Ended 31St… | +9.9% | +9.0% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 12 November 2026: Board meeting — Financial Results.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.